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Background: The type VI secretion system (T6SS) is involved in bacterial warfare.
Results:Novel H1-T6SS-dependent toxins from Pseudomonas aeruginosa are identified using an in vitro bacterial killing assay.
Conclusion: The newly identified toxins showed a requirement for specific VgrG proteins.
Significance:VgrG proteins may represent an independent form of T6SS-dependent secretion, resembling the contact-depen-
dent growth inhibition (CDI) system.
The bacterial type VI secretion system (T6SS) is a supra-mo-
lecular complex akin to bacteriophage tails, with VgrG proteins
acting as a puncturing device. The Pseudomonas aeruginosa
H1-T6SS has been extensively characterized. It is involved in
bacterial killing and in the delivery of three toxins, Tse1–3.
Here, we demonstrate the independent contribution of the
three H1-T6SS co-regulated vgrG genes, vgrG1abc, to bacterial
killing. A putative toxin is encoded in the vicinity of each vgrG
gene, supporting the concept of specific VgrG/toxin couples. In
this respect, VgrG1c is involved in the delivery of anRhs protein,
RhsP1. The RhsP1 C terminus carries a toxic activity, from
which the producing bacterium is protected by a cognate immu-
nity. Similarly, VgrG1a-dependent toxicity is associated with
thePA0093gene encoding a two-domainproteinwith aputative
toxin domain (Toxin_61) at theC terminus. Finally, VgrG1b-de-
pendent killing is detectable upon complementation of a triple
vgrG1abc mutant. The VgrG1b-dependent killing is mediated
by PA0099, which presents the characteristics of the superfam-
ily nuclease 2 toxin members. Overall, these data develop the
concept that VgrGs are indispensable components for the spe-
cific delivery of effectors. Several additional vgrG genes are
encoded on the P. aeruginosa genome and are not linked genet-
ically to other T6SS genes. A closer inspection of these clusters
reveals that they also encodeputative toxins.Overall, these asso-
ciations further support the notion of an original form of secre-
tion system, in which VgrG acts as the carrier.
The type VI secretion system (T6SS)4 is present in most
Gram-negative bacteria and is used to outcompete other
microorganisms (1, 2). This machinery is mechanistically akin
to the bacteriophage tail-like injection device (3), but the tail
tube is composed of the bacterial Hcp protein (4). The punctur-
ing device capping the Hcp tube has been identified as a mem-
ber of the VgrG family of proteins. These proteins contain two
conserved domains that share similarity with T4 phage bacte-
riophage proteins, namely the gp27 and the gp5 proteins, cor-
responding to the N- and C-terminal parts of VgrG, respec-
tively (5). The gp5-like domain displays a rigid -stranded
helical structure and is shaped as a needle-like component. In a
few cases it has been shown that the VgrG C terminus, which is
considered as a spike, could further be sharpened by the addi-
tion of a protein carrying a PAAR domain, which adopts a rigid
conical shape (6). The Hcp tube has been proposed to fit within
a contractile sheath-like structure, which is composed of the
TssB and TssC proteins (7–10). The contraction of the sheath
results in the propelling of the tube and puncturing device
across cell membranes (11–13). After contraction, the ClpV
AAA ATPase disassembles the sheath components by binding
the TssC proteins, and a new cycle of T6SS assembly can be
restarted (12, 14).
In Pseudomonas aeruginosa, one of the three known T6SSs,
H1-T6SS, is well characterized and is an archetypical example
of a bacterial toxin delivery machine (4). Expression of the
H1-T6SS cluster is regulated by a signaling cascade which
involves the Gac/Rsm pathway (15–17). The RetS sensor coun-
teracts theGacS sensor kinase (18). Thus, in aP. aeruginosa retS
mutant, the Gac pathway remains active and leads to a consti-
tutively active and functional H1-T6SS. All core components of
the T6SS are encoded by the H1-T6SS cluster, which also con-
tains a few additional accessory genes (19–21). Two vgrG genes,
namely vgrG1a and vgrG1b, belong to this cluster (22).
Although located on a different region of the chromosome, an
additional gene, vgrG1c, is co-regulated with the H1-T6SS
genes and thus induced in a retS background (22). Importantly,
three gene couples have also been shown to be controlled by the
RetS signaling pathways and encode toxin/immunity pairs
involved in H1-T6SS-dependent bacterial killing (23–25). Tse1
and Tse3 have been characterized biochemically as amidases
and are involved in the degradation of peptidoglycan. Tsi1 and
Tsi3 are periplasmic immunity proteins and protect the cells
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from the deleterious effects of the cognate toxins. This family of
toxins is broadly conserved in other T6SS-positive organisms
such as Serratia marcescens (26, 27). The function of Tse2
remains elusive but is likely targeted to the cytoplasm where it
exerts a bacteriostatic activity that could be counteracted by the
Tsi2 protein (23). All three toxins are injected into neighboring
cells, competitors, or siblings in an H1-T6SS-dependent man-
ner. These toxins are very potent and allow P. aeruginosa to
outcompete a broad range of other Gram-negative bacteria
(28). Interestingly, whereas a retS mutant randomly attacks
neighboring cells, a wild-type strain might only respond via a
Tit-for-Tat mechanism (29).
Although the mechanism of assembly/contraction of the
T6SS is beginning to be well documented (12), the precise
mechanisms by which the toxins are delivered into the target
cells remain elusive. TheHcp tube displays an internal diameter
of 40 Å and could very well accommodate transiting unfolded
effectors (4, 30). Recent data have demonstrated the presence of
Tse2 protein within a hexameric Hcp ring (31). It was thus
proposed that Hcp could act as a chaperone for T6SS effectors
and not only as a component of the tail tube. These two func-
tions are not exclusive as a stack of Hcp rings containing Tse2
could be fitted within the T6SS sheath, thus forming a pile of
rings (or tube) that could be propelled by the contraction of the
sheath. An alternative hypothesis came from the description of
VgrG proteins displaying C-terminal extension with a catalytic
activity, as exemplified by the VgrG3 protein ofVibrio cholerae
(32, 33). This protein possesses a domain extension to its gp5
region that bears a peptidoglycan hydrolase activity. In this case
the VgrG protein can be considered as the carrier located at the
tip of the T6SS. Based on this observation, it is also reasonable
to propose that genuine T6SS effectors could go for a “piggy-
back ride” by interacting with the tip of non-evolved VgrGs. A
sophisticated concept has been proposed in which adaptors
such as the PAAR proteins connect the T6SS toxin/effector to
the tip of the VgrG proteins (6).
In the present study we lend support to this hypothesis by
showing that the three VgrG proteins co-expressed with the
H1-T6SS individually contribute to the toxicity exerted by a
retS strain against Escherichia coli targets (34). This toxicity is
observable in a background devoid of the characterized Tse1–3
toxins, thus revealing a broader repertoire of T6SS toxins.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions—Bacterial strains
used in this study are described in Table 1. P. aeruginosa strains
were grown in Tryptone soy broth or LB supplemented with
antibiotics where appropriate (streptomycin 2000g/ml, tetra-
cycline 200 g/ml) at 37 °C with agitation. E. coli strains were
grown in LB broth supplementedwith antibiotics where appro-
priate (streptomycin, 50 g/ml; ampicillin, 50–100 g/ml;
kanamycin, 50g/ml; chloramphenicol, 34g/ml; tetracycline,
15 g/ml).
DNA Manipulation—DNA purification was performed
using the PureLink Genomic DNA minikit (Invitrogen). Isola-
tion of plasmid DNA was carried out using the QIAprep spin
miniprep kit (Qiagen). Restriction endonucleases were used
according to the manufacturer’s specifications (New England
Biolabs or Roche Applied Science). Oligonucleotides used are
shown inTable 2 andwere purchased fromSigma. The genes or
DNA fragments used for the construction of deletion mutants
were amplified with KOD Hot Start DNA Polymerase (Nova-
gen) as described by the manufacturer with the inclusion of
Betaine (Sigma). Colony PCRwas performedwith standardTaq
polymerase (New England Biolabs). DNA sequencing was per-
formed by GATC Biotech.
DNA fragments encoding Rhs C-terminal putative toxin
and putative immunity constructs were ordered as synthetic
DNA constructs from GeneArt (Invitrogen). Constructs
were designed using an 18-bp sequence including the Shine-
Dalgarno sequence from pBAD (35) followed by an ATG start
codon fused to the DNA sequence occurring directly after that
encoding for the characteristic Rhs PXXXXDPXGLmotif or the
sequence of the predicted immunity gene followed by that
encoding the V5his tag (from pET-DEST42 (Invitrogen)). The
constructs encoding the putative C-terminal toxins and immu-
nities were then subcloned from the GeneArt vectors into
pNDM220 and pBAD33, respectively (36). DNA sequencing
was performed by GATC Biotech.
Overexpression of Toxin/Immunity Pairs in E. coli—Growth
curves were performed in 10-ml flasks. Briefly, overnight cul-
tures of E. coli cells carrying plasmids encoding RhsP1-CT/
RhsI1 or RhsP2-CT/RhsI2 were diluted in fresh LBmedia to an
A600 of 0.1 with appropriate antibiotics. Cultures were incu-
bated at 37 °C with agitation, and readings were taken hourly.
Toxin/immunity expression was then induced with 1 mM
isopropyl 1-thio--D-galactopyranoside or 0.02% arabinose,
respectively.
Construction of P. aeruginosa Deletion Mutants—P. aerugi-
nosa deletion mutants were constructed as described previ-
ously (37) using the suicide plasmid pKNG101 (38, 39). Briefly,
to create PAKgene-of-interest (GOI), 500-bp DNA fragments
of the 5 (up) and 3 (down) ends of the target gene were
obtained by PCR using PAK chromosomal DNA as the tem-
plate with two pairs of oligonucleotides (Up5/Up3 and
Down5/Down3) (Table 2). The fused up/down fragment was
obtained by overlapping PCR, cloned into pCR-BluntII-TOPO
(Invitrogen), sequence-confirmed, and subcloned into pKNG101
suicide vector. The plasmid pKNG-GOI was maintained in the
E. coli strain CC118pir and mobilized into P. aeruginosa PAK
using E. coli 1047 carrying the conjugative plasmid pRK2013 (40).
Clones in which double recombination events occurred, resulting
in the deletion of GOI, were selected on sucrose plates as previ-
ously described (37). Deletion of GOI was verified by PCR using
external primers andWestern blot analysis where appropriate.
Insertion of vgrGGenes at the P. aeruginosa Chromosomal att
Site—For complementation of the triple vgrG1abc mutant by
vgrG1b and vgrG1c, the DNA sequences including 300 bp
upstream of the vgrG1b and vgrG1c genes were amplified and
cloned into pCR-BluntII-TOPO. The genes were then excised
and subcloned into Mini-CTX-1 (20) to construct Mini-CTX-
vgrG1b and Mini-CTX-vgrG1c. As for vgrG1a, the gene was
amplified and cloned under a plac promoter leading to the con-
struct Mini-CTX-plac-vgrG1a. These plasmids were conju-
gated by tri-parental mating using pRK2013 into the appropri-
ateP. aeruginosa strains, and the presence of the corresponding
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vgrG gene was confirmed by both PCR and Western blot anal-
ysis where appropriate.
Bacterial Competition Assay—Overnight cultures of P.
aeruginosa strains were mixed individually with equivalent
numbers of the prey E. coli DH5 pCR2.1 expressing -galac-
tosidase (34). After co-incubation on LB agar for 5 h at 37 °C,
patches of bacteria were recovered and resuspended in Tryp-
tone soy broth. Samples were serially diluted 0 to 107 and
spotted in triplicate on LB plates containing 100 g/ml 5-bro-
mo-4-chloro-indolyl--D-galactopyranoside (X-gal) (Invitro-
gen). The level of blue color indicates survival of lacZ-positive
E. coli. Alternatively, and for quantitative analysis of prey sur-
vival, E. coliDH5 containing pRL662-gfpwas used as the prey,
and spotting was performed on LB plates. The level of fluores-
cence indicates survival of E. coli. For quantification, the spots
from the 102 dilution were resuspended in sterile PBS, diluted
to 1:20, and pipetted into a 96-well, black/clear flat bottomplate
(BD Bioscience, Falcon). Fluorescence emitted by the surviving
prey cells was measured using a Fluostar Omega plate reader
(BMG Labtech).
Subcellular Fractionation—E. coli strains producing recom-
binant proteins were collected by centrifugation and resus-
pended in 10 mM Tris, pH 8.0, supplemented with Complete
Protease Inhibitor Mixture (Roche Applied Science) and 1 mM
TABLE 1
Strains and plasmids used in this work
Strain or plasmid Relevant characteristicsa Source/Reference
Strain
E. coli
Dh5 F80lacZM15 (lacZYA-argF) U169 recA1 endA1 hsdR17 (rK, mK) phoA
supE44 -thi-1 gyrA96 relA1
Laboratory collection
Top10 FmcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 araD139 (ara
leu) 7697 galU galK rpsL (StrR) endA1 nupG
Laboratory collection
CC118(pir) Host strain for pKNG101 replication; (ara-leu) araD lacX74 galE galK-phoA20
thi-1 rpsE rpoB argE (Am) recA1 Rfr (pir)
Laboratory collection
P. aeruginosa
PAK Wild-type prototroph Laboratory collection
PAKretS retS deletion mutant (15)
PAKretSvgrG1a vgrG1a deletion mutant (22)
PAKretSvgrG1b vgrG1b deletion mutant (22)
PAKretSvgrG1c vgrG1c deletion mutant (22)
PAKretSvgrG1abc vgrG1a/vgrG1b/vgrG1c deletion mutant (22)
PAKretStsei1–3 tse1tsi1/ tse2tsi2/tse3tsi3 deletion mutant This work
PAKretSvvgrG1abctsei1–3 vgrG1abc/tsei1–3 deletion mutant This work
PAKretSvgrG1abctsei1–3::vgrG1a vgrG1abc/tsei1–3 deletion mutant complemented in trans with vgrG1a This work
PAKretSvgrG1abctsei1–3::vgrG1b vgrG1abc/tsei1–3 deletion mutant complemented in trans with vgrG1b This work
PAKretSvgrG1abctsei1–3::vgrG1c vgrG1abc/tsei1–3 deletion mutant complemented in trans with vgrG1c This work
PAKretStsei13vgrG1abcH1::vgrG1c vgrG1abc/tsei1–3/H1-T6SS deletion mutant complemented in trans with vgrG1c This work
PAKretStsei13vgrG1abcrhsP1::vgrG1c vgrG1abc/tsei1–3/rhsP1 deletion mutant complemented in trans with vgrG1c This work
PAKretStsei1–3vgrG1ab vgrG1ab/tsei1–3 deletion mutant This work
PAKretStsei13vgrG1abrhsP1-CT vgrG1ab/tsei1–3/rhsP1-CT deletion mutant
PAKretStsei1–3vgrG1bc vgrG1bc/tsei1–3 deletion mutant This work
PAKretStsei13vgrG1bcPA0093 vgrG1bc/tsei1–3/PA0093 deletion mutant This work
PAKretSvgrG1aPA0099 vgrG1a/vgrG1c/PA0099 deletion mutant This work
Plasmids
pRK2013 TraMob, KmR Laboratory collection
pCR2.1 TA cloning vector, ApR, KmR Invitrogen
pCR-BluntII-TOPO Blunt cloning vector, ZeoR, KmR Invitrogen
pRL662-gfp GmR, broad host range vector derived from pBBR1MCS-2 expressing Gfp Erh-Min Lai
collection
pKNG101 Suicide vector, sacB, StrR (39)
pKNG101-vgrG1a pKNG101-vgrG1amutator (22)
pKNG101-vgrG1b pKNG101-vgrG1bmutator (22)
pKNG101-vgrG1c pKNG101-vgrG1cmutator (22)
pKNG101-tsei1 pKNG101-tsei1mutator This work
pKNG101-tsei2 pKNG101-tsei2mutator This work
pKNG101-tsei3 pKNG101-tse3mutator This work
pKNG101-H1-T6SS pKNG101-H1-T6SS mutator (34)
pKNG101-rhsP1 pKNG101-rhsP1mutator This work
pKNG101-rhsP1-CT pKNG101-rhsP1-CTmutator This work
pKNG101-PA0093 pKNG101-PA0093mutator This work
pKNG101-PA0099 pKNG101-PA0099mutator This work
Mini-CTX-1 Plasmid for the integration of genes into the att site of the P. aeruginosa
chromosome, TcR
Laboratory collection
Mini-CTX-plac-vgrG1a Mini-CTX-1 encoding vgrG1a under a plac promoter for integration into the att
site of the P. aeruginosa chromosome for the purpose of complementation, TcR
This work
Mini-CTX-vgrG1b Mini-CTX-1 encoding vgrG1b under its native promoter for integration into the att
site of the P. aeruginosa chromosome for the purpose of complementation, TcR
This work
Mini-CTX-vgrG1c Mini-CTX-1 encoding vgrG1c under its native promoter for integration into the att
site of the P. aeruginosa chromosome for the purpose of complementation, TcR
This work
pNDM220 Low copy number cloning vector containing lacIq and the LacI-regulated
pA1/O4/O3
(36)
pBAD33 L-arabinose inducible, CmR, p15A origin (35)
pRhsP1-CT pNDM220 expressing rhsP1-CT This work
pRhsI1 pBAD33 expressing rhsI1 This work
pRhsP2-CT pNDM220 expressing rhsP2-CT This work
pRhsI2 pBAD33 expressing rhsI2 This work
a ApR, ampicillin resistant; StrR, Streptomycin resistant; KmR, kanamycin resistant; TcR, tetracycline resistant; ZeoR, zeocin-resistant.
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EDTAbefore cells were lysed by sonication (3 30 s, amplitude
of 35%) using a Vibra-Cell ultrasonic processor (Sonics). Intact
cells were removed by centrifugation at 4000  g for 5 min at
4 °C. Soluble and membrane fractions were separated by cen-
trifugation at 100,000  g for 1 h at 4 °C. The membrane frac-
tionwas resuspended in 15mMTris, pH7.4, supplementedwith
1% Triton X-100 (Sigma) for 30 min at 4 °C. Soluble and insol-
uble membrane proteins were separated by centrifugation at
100,000 g for 1 h at 4 °C. The proteins contained in the vari-
ous fractions were analyzed by SDS-PAGE.
Separation of E. coliMembranes by Density Sucrose Gradient—
E. coli strains producing recombinant proteins were harvested
by centrifugation (2000 g). The pellet of 250A600 units equiv-
alent of bacterial cells was resuspended in 1.5ml of buffer A (10
mM Tris, pH 7.6, 10 g/ml DNase (Sigma), Complete Protease
Inhibitor Mixture (Roche Applied Science), and sucrose 20%
(w/w) (Sigma)). The cells were passed through a French press
cell disruptor (SIM-AMICO) at 1500 pressure units (p.s.i.)
using a 3/8-inch-diameter piston (20K French pressure cell,
Thermo). Unbroken cells and possible inclusion bodies were
removed by two cycles of centrifugation at 4 °C for 15 min at
1600 g. The resulting supernatant was centrifuged at 4 °C for
1 h at 125,000  g. The collected crude membrane pellet was
resuspended in 0.5 ml of buffer M (10 mM Tris, pH 7.4, com-
plete protease inhibitor mixture (Roche Applied Science), and
sucrose 20% (w/w)). Themembrane fractionwas then added on
top of a discontinuous sucrose gradient consisting of 1.5-ml
layers ranging from 60% (bottom) to 30% by 5% increments and
separated according to the method described previously (41).
Fractions of 500 l were collected, and the protein content was
analyzed by SDS-PAGE and Western blot.
WesternBlotAnalysis and SDS-PAGE—For SDS-PAGEanal-
ysis, cell extracts were loaded onto SDS-polyacrylamide gels,
migrated, and transferred to a nitrocellulose membrane at 3
mA/cm2. After transfer, membranes were blocked overnight in
blocking buffer (5% milk powder, 0.1% Tween 20 in Tris-buff-
ered saline, pH 8.0). Polyclonal antibodies against VgrG1a were
used at a dilution of 1:1000 (22). Monoclonal anti-V5 antibody
(Invitrogen) was used at a dilution of 1:5000. Monoclonal anti-
bodies were used against the  subunit of RNA polymerase
(NeoClone) 1:1000. Antibodies against PhoE and SecA were
kindly provided by Jan Tommassen (Utrecht University) and
used at a dilution of 1:2000 and 1:1000, respectively. Secondary
antibodies conjugated to horseradish peroxidase were used at a
dilution of 1:5000. Western blots were developed using Super-
Signal West Pico Chemiluminescent Substrate (Pierce) and
visualized on a LAS3000 Fuji Imager.
Bioinformatic Analysis—DNA sequences were obtained from
Pseudomonas Genome Database (42). Amino acid sequence
searches were performed using SMART, Interscanpro, Pfam,
TABLE 2
Oligonucleotides used in this study
Oligonucleotide sequencea
Deleted gene/oligonucleotide
tsei1
Up5 TGGACGTCACGGCTATAGGAA
Up3 CCTGGGCAGCAGTTTCATGGGGCGGGTTCT
Down5 ATGAAACTGCTGCCCAGGGCCAGTTGATTC
Down3 AGGTCGTTGTTGCCTTTCAC
tsei2
Up5 ACCACTGGTCGACGAAGAGGTGGAC
Up3 TCAGGATGCGTAGGACATGCGTGGACT
Down5 ATGTCCTACGCATCCTGACGGCCCGTG
Down3 CTTCAGCAGCAGCGCACCAGCTAC
tsei3
Up5 ACCAGACCCTGCAGCAATAC
Up3 CTGCAACCTGGTCATCGGTCTTCCTCCTTG
Down5 CCGATGACCAGGTTGCAGTGAGCGCGA
Down3 CTGGAGGAAGCCGTATTCAG
rhsP1
Up5 GCTGAACGGCTTCGGCAGGTAGTC
Up3 GATCTGCTTAATAGCCACGACACTCCT
Down5 GTGGCTATTAAGCAGATCGTCAAATGC
Down3 GTCGAGGGTACGCGAGGACATCAC
PA0093
Up5 GTTCCTCACCCGCATGCTCGAAG
Up3 ATGGATGCGGGATCATGAATGACACCC
Down5 CGCATCCATGCGTCGGTACTCGGGTCA
Down3 GCCTTGATTCGCGAGCAACATTCCG
PA0099
Up5 AGTCGATTCCTACCTGACCG
Up3 CTATGGACGGTTGGCCATCTAGTTCGC
Down5 ATGGCCAACCGTCCATAGGAACTGAAC
Down3 AGTAGAGCGGCAGGTTGG
Amplified gene/oligonucleotide
vgrG1a
5 CGGGATCCTTCACACAGGAAACAGCTATGCAACTGACCCGC
3 CGAGCTCTCAGCCCTTCGCCGGCGGCGGAAACAT
vgrG1b
5 GGATCCCTTTCGTGATGGCCTTCTG
3 TGACTCCCTGGCTCTGCGCCGCTTCAGTTC
vgrG1c
5 GGATCCAGCATGATGTCCAGCAACAC
3 AAGCTTCGCTCAACAGTTGATATCGAC
aOligonucleotides are presented in the orientation 5-3.
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BlastP, and PSI-BLAST software programs as implemented on
the NCBI (National Center for Biotechnology Information)
website. Secondary structure was predicted using PSI-PRED
software program. Fold recognition was performed using
Phyre2 (43) and I-TASSER (44). The TMHMMserver was used
to predict transmembrane helices in proteins.
RESULTS
ABroad Repertoire of Toxins Involved inH1-T6SS-dependent
Killing—P. aeruginosa H1-T6SS secretes a set of three toxins,
namely Tse1–3 (24), and the producing strains are protected
from the activity of the Tse by cognate immunity proteins,
Tsi1–3. The H1-T6SS and all three toxins/immunity pairs are
up-regulated in a retS genetic background (23). The use of
E. coli as target cells in an in vitro bacterial killing assay (34)
shows a bactericidal activity mediated by a P. aeruginosa retS
mutant but not by the parental PAK strain (Fig. 1). The deletion
of theH1-T6SS cluster in the retS background (PAKretSH1)
totally abrogates E. coli killing. By contrast, E. coli killing is still
clearly observable upon simultaneous deletion of the tse1–3 genes
in the retS strain (PAKretStsei1–3) (Fig. 1). This demonstrates
the existence of additional uncharacterized H1-T6SS-dependent
toxins.
VgrGProteinsAre Required for ToxinDelivery—The retS reg-
ulatory pathway positively controls the expression of three vgrG
genes, two of which are encoded within the H1-T6SS cluster,
vgrG1a and vgrG1b, whereas the third, vgrG1c, is distally
located (22). Individual vgrG gene deletion in the retS strain
does not impact the ability of P. aeruginosa to kill E. coli; how-
ever, simultaneous deletion of all three vgrG genes totally abro-
gates killing (PAKretSvgrG1abc) (Fig. 2), just as observed
with a H1-T6SSmutant. This observation suggests that if addi-
tional H1-T6SS-dependent toxins do exist, they require one of
the VgrGs for transport and injection into target cells.
Genetic and Functional Linkage between vgrG1c and a rhs
Gene—A plausible hypothesis is that if additional toxins need
aVgrGprotein for transport, the corresponding geneswould be
encoded in the vicinity of a vgrG gene. The vgrG1c gene is con-
tiguous to a large gene (PA2684) that encodes a protein of the
Rhs family (45), re-named RhsP1 (Fig. 3A). Previous reports
indicated that Rhs proteins are involved in contact-dependent
growth inhibition (CDI) and are thus potential bacterial toxins
(46). A series ofmutants have been engineered to assess the role
of RhsP1 in bacterial killing and the possible connection with
VgrG1c. To avoid any interference in our assay, these mutants
were engineered in the PAKretStsei1-3 strain. The deletion
of the vgrG1abc genes yielded the PAKretStsei1–3
vgrG1abc strain, lacking all tse and vgrG genes. As expected, this
strain is completely innocuous for E. coli (Fig. 4A). The vgrG1c
gene was then reintroduced at the att site on the chromosome of
the PAKretStsei1–3vgrG1abc strain using amini-CTX deliv-
ery system (PAKretS tsei1–3vgrG1abc::vgrG1c). The pres-
ence/absence of VgrG1c in these genetic backgrounds was con-
firmed by Western blot analysis using anti-VgrG polyclonal
antibodies (Fig. 4B).Remarkably,E. colikillingwas readily restored
FIGURE 1. P. aeruginosa H1-T6SS-dependent bacterial killing involves more effectors than the Tse1–3 toxins. A, cultures of P. aeruginosa strains PAK,
PAKretS, PAKretSH1, and PAKretStsei1–3were mixed individually at a 1:1 ratio with E. coli DH5 prey cells expressing -galactosidase (34). Recovered
bacteriawere diluted 0 to 107 and spotted on LB plates containing X-gal. The level of blue color indicates survival of E. coli. B, bacterial killingmediated by the
strains PAKretS, PAKretS deleted for the H1-T6SS genes (PAKretSH1), or PAKretS deleted for the tse1–3 and tsi1–3 genes (PAKretStsei1–3) against
DH5 expressing the green fluorescent protein. The level of fluorescence indicates survival of E. coli. C, quantification of the fluorescence shown in B as an
indicator of bacterial killing. Bacterial spots were resuspended from the plates, and the residual fluorescence, reflecting E. coli survival, was measured and
reported in arbitrary units (A.U.).
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upon complementation with the vgrG1c gene, which suggested
that either VgrG1c has an intrinsic killing activity or
that it is required for the transport of a toxin, which is not Tse1–3.
It should be noted that the VgrG1c-dependent killing is
H1-T6SS-dependent as deletion of this T6SS cluster in the
PAKretStsei1–3vgrG1abc::vgrG1c strain abrogatesE. colikill-
ing (Fig. 4A).The lackofT6SS in thisbackgroundwasalsoassessed
byWestern blot using an antibody directed against the T6SS core
component HsiB1 (Fig. 4B).We then tested whether RhsP1 could
be associated with the VgrG1c-dependent killing. The rhsP1 gene
was deleted in the PAKretStsei1–3vgrG1abc::vgrG1c strain
(PAKretS tsei1–3vgrG1abcrhsP1::vgrG1c), which yielded a
strain innocuous for E. coli. We concluded that RhsP1 carries a
bacterial toxin activity and that this protein is delivered to target
cells in a VgrG1c-dependent manner.
The C Terminus of RhsP1 Is a Bacterial Toxin Domain—Rhs
proteins, such as in Dickeya dadantii, are involved with CDI
systems, and the toxic activity is carried in the C-terminal
domain (Rhs-CT) (47). This Rhs-CT domain is clearly distin-
guishable and preceded by a PXXXXDPXGL motif. In case of
RhsP1, the motif PTLAYDPTGL precedes a 149-aa long puta-
tive toxin domain (Fig. 3B). Furthermore in the CDI system, the
toxin gene is usually organized in tandem with an immunity-
encoding gene (cdiI). Although no obvious immunity gene is
annotated directly downstream of PA2684 (rhsP1), a small orf
overlapping with rhsP1 could be predicted using ORF finder,
which encodes a 76-aa-long protein (Fig. 3A). We named this
putative gene rhsI1 for rhsP1 immunity. To assess the function-
ality of RhsP1-CT/RhsI1 as a toxin/immunity couple, con-
structs encoding His6-V5-tagged versions were produced and
cloned into compatible and independently inducible plasmids,
pNDM220 and pBAD33 (35, 36). The production of both pro-
teins was induced either by isopropyl 1-thio--D-galactopyran-
oside (pNDM220) or arabinose (pBAD33) and confirmed by
Western blot analysis using anti-V5 antibodies (Fig. 5A). The
impact of RhsP1-CT production on E. coli growth was then
tested. Upon isopropyl 1-thio--D-galactopyranoside induc-
tion the toxin is produced, and growth inhibition could be
observed by a drastic drop in the A600 of the culture 4 h post-
induction (Fig. 5B). Remarkably, this drop in A600 is no longer
observablewhen arabinose is also added to the culture, suggest-
ing that RhsI1 is able to protect E. coli from the RhsP1-CT toxic
effect (Fig. 5B).
The target for the toxic activity mediated by RhsP1 is
unknown. RhsI1 is predicted to have two transmembrane
FIGURE 2. VgrG1abc proteins are required for toxicity. A, killing assay assessing the bactericidal activity of the P. aeruginosa strain PAKretS, PAKretS
lacking either vgrG1a, vgrG1b, or vgrG1c (PAKretSvgrG1a, PAKretSvgrG1b, or PAKretSvgrG1c, respectively), lacking all three vgrGs
(PAKretSvgrG1abc) and PAKretS lacking the H1-T6SS cluster (PAKretSH1) against DH5 expressing GFP. The level of fluorescence indicates survival of
E. coli. B, quantification of thebacterial killingmediatedby the vgrGmutants. Bacterial spotswere resuspended fromA, and the relative fluorescence, reflecting
E. coli survival, was measured and reported in arbitrary units (A.U.).
FIGURE 3.A rhs gene is encoded downstreamof vgrG1c. A, genetic organi-
zationof the vgrG1c cluster showing vgrG1c (PA2685), rhsP1 (PA2684), and the
non-annotated immunity protein rhsI1 and PA2683. B, schematic representa-
tion of RhsP1 displaying the N-terminal region, RVXXXXXXXXG motif, con-
served Rhs core domain, PXXXXDPXGL motif, and the C-terminal domain
(RhsP1-CT). C, TMHMM prediction of RhsI1 highlighting the two putative
transmembrane domains.
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domains, which likely results in the protein forming a hairpin
loop in the cytoplasmic membrane (Fig. 3C). Subcellular local-
ization experiments and Western blot analysis (Fig. 5C) show
the presence of RhsI1 in the inner membrane. To further sup-
port this observation, the crude membrane fraction was loaded
on a sucrose gradient (Fig. 5D). RhsI1 is mainly distributed in
the fractions containing the innermembrane (from fractions 11
to 17 in Fig. 5D) along with the inner membrane-associated
SecA protein. Instead, the outer membrane marker is more
abundant in fractions 1–9 (Fig. 5D). RhsP1-CT appears mainly
in the soluble fraction (Fig. 5C), suggesting it might be periph-
erally associated to the membrane upon interaction with the
immunity protein.
Finally, we assessed the role of RhsP1-CT in the bacterial
killing assay previously described. A strain deleted for
vgrG1a and vgrG1b but in which the native vgrG1c gene is
still present (PAKretStsei1–3vgrG1ab) shows signifi-
cant toxicity against E. coli (Fig. 4A). In this background,
deletion of the DNA region encoding the RhsP1-CT domain
only (PAKretStsei1–3vgrG1abrhsP1-CT) abrogates
E. coli killing ability (Fig. 4A), which confirmed the bacteri-
cidal activity conferred by the C terminus of RhsP1.
VgrG1a Mediates a PA0093-dependent Bacterial Killing—
The specific contribution of VgrG1c to the RhsP1-mediated tox-
icity led us to investigate whether other H1-T6SS-related VgrG
proteinsare linkedtoyetuncharacterized toxins. In thestrain lack-
ing all three vgrG genes, PAKretStsei1–3vgrG1abc, the
vgrG1a gene was reintroduced at the att site on the chromosome
(PAKretStsei1–3vgrG1abc::vgrG1a), as described previously.
It was observed that killing is restored by the introduction of
VgrG1a (Fig. 6), similar to what was previously observed with
VgrG1c (Fig. 4A). In contrast to VgrG1c, the killing mediated
by VgrG1a appears to be independent of RhsP1, as a strain
lacking the rhsP1 gene but expressing vgrG1a (PAK
retStsei1–3vgrG1abcrhsP1::vgrG1a) is able to kill E. coli
prey cells, which is not the case upon complementation by
vgrG1c (PAKretStsei1–3vgrG1abcrhsP1::vgrG1c) (Fig.
6). This observation suggests a high degree of specificity for
the VgrG proteins toward their cognate toxin partner (Fig.
6). Directly downstream of the vgrG1a gene lies a three-gene
cluster (PA0092-PA0094). Among these, PA0093 encodes a
430-aa-long PAAR-containing protein (Fig. 7A). Some
PAAR proteins (proline-alanine-alanine-arginine-repeat
proteins) were proposed to be located at the tip of VgrG
proteins (6). Furthermore, whereas the PAAR domain of
PA0093 (aa 74–162) is found at the N terminus, the C-ter-
minal region is predicted to carry a putative toxin domain (aa
266–422), named Toxin_61 (Fig. 7B), as defined using the
comprehensive polymorphic toxin systems described by
Zhang et al. (48). This particular domain displays an - fold
and bears a conserved glutamine residue as well as a recog-
nizable (K/R)STXXPXXDXX(S/T) motif (RSTAAPTDD-
FWS). In light of these observations, it is conceivable that
PA0093 could use VgrG1a as a carrier. To assess this hypoth-
esis, the gene encoded by PA0093 has been deleted in the
strain PAKretStsei1–3vgrG1bc (PAKretStsei1–
3vgrG1bcPA0093), which is lacking vgrG1b and vgrG1c
but still possesses the vgrG1a gene. Although bacterial kill-
ing is still potent when using a strain carrying only VgrG1a,
the loss of PA0093 in this background totally abrogates the
phenotype (Fig. 7C), thus confirming the functional relation-
ship between VgrG1a and PA0093.
FIGURE4.RhsP1isaH1-T6SSbacterialtoxinthatrequiresVgrG1cforkilling.The
strainslackingallthreeTsetoxins(PAKretStsei1–3) isusedasthebackgroundstrain
with additional deletions () or insertion at the chromosomal att site (::) where indi-
cated.A,quantificationofbacterialkillingbyPAKretS,PAKretStsei1–3vgrG1abc,
PAKretStsei1–3vgrG1abc::vgrG1c, PAKretStsei1–3vgrG1abcH1::vgrG1c,
PAKretStsei1–3vgrG1abcrhsP1::vgrG1c, PAKretStsei1–3vgrG1ab, and
PAKretStsei1–3vgrG1abrhsP1-CTagainstDH5expressingGFP.Bacterial spots
were resuspended fromplate killing assays, and the relative fluorescencewasmea-
sured. The level of fluorescence indicates survival of E. coli. Complementation of
vgrG1c inPAKretStsei1–3vgrG1abcrestoresE. colikilling.VgrG1cdoesnotrestore
killing in aH1-T6SSor rhsP1mutant. PAKretStsei1–3vgrG1ab, which carries only
thevgrG1cgene,readilykillsE. coli(secondfromtheright).Thiskillingisabrogatedifthe
regionencodingtheC-terminaldomainofRhsP1 isdeleted(lastbar).B, thepresence
andabsenceofVgrG1c in thevariousgeneticbackgroundswasconfirmedbyWest-
ern blot analysis using anti-VgrG polyclonal antibodies (22). The presence and
absence of H1-T6SSwas confirmed byWestern blot analysis using anti-HsiB1 poly-
clonal antibodies (20).A.U., arbitraryunits.
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FIGURE 5.RhsP1 andRhsI1 formaT6SS toxin/immunity pair.A, Western blot analysis using an anti-V5 antibody demonstrating expression of RhsP1-CT and
RhsI1.B,monitoringgrowth (A600) in LBmediumof E. coliTop10cells harboringpRhsP1-CTandpRhsI1plasmids. Expressionof RhsP1-CTandRhsI1was induced
at the time indicated (see the arrow) with either 1 mM isopropyl 1-thio--D-galactopyranoside (expression of the RhsP1-CT toxin) or 0.02% arabinose (expres-
sion of the RhsI1 immunity). Expression of RhsP1-CT compromised growth (red curve). Co-expression of RhsI1 rescue growth (purple curve).C, fractionationwas
performed to determine the subcellular localization of RhsP1 and RhsI1 using appropriate controls, i.e. RNA polymerase (RNA Pol, cytosolic), SecA (inner
membrane-associated), and PhoE (outer membrane). Western blot analysis was performed using specific antibodies with the exception of the anti-V5 anti-
body, whichwas used to detect V5-tagged RhsP1 and RhsI1. RhsI1 ismostly located in the innermembrane fraction (IM), whereas RhsP1 is found in the soluble
fraction (SF). WCL, whole cell lysate; TM, total membrane fraction; OM, outer membrane fraction. D, the crude membrane extract was separated on a density
sucrose gradient by ultracentrifugation to determine the membrane localization of RhsI1 in E. coli as described previously (41). Collected fractions were
analyzed by SDS-PAGE andWestern blot using the antibodies described in C. The percentage of sucrose in the collected fractions (1–18) is shown on top, and
the fractions containing either inner membrane (IM) or outer membrane (OM) proteins are delineated underneath the panels.
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The toxic nature of PA0093 suggests that there may be an
associated immunity. The two other genes in the PA0093 clus-
ter, PA0092 and PA0094, encode proteins of 94 and 144 resi-
dues, respectively. Both proteins have neither predicted trans-
membrane domains (TMHMM) nor a signal peptide (SignalP
4.1), which suggests a cytosolic localization.
VgrG1b Contributes to Bacterial Killing—According to our
results, both VgrG1a and VgrG1c contribute to the delivery of
specific effectors resulting in the killing of prey cells. To assess if
such role could also be assigned to VgrG1b, the vgrG1b gene
was reintroduced at the att site in a strain lacking all three
vgrG1abc genes (PAKretStsei1–3vgrG1abc::vgrG1b). This
strain clearly shows a partial recovery of killing ability (Fig. 8A).
We hypothesized that the VgrG1b-dependent killing could be
linked to another toxin encoded among the six genes of the
cluster (PA0096-PA0101) lying downstream of vgrG1b
(PA0095) (Fig. 8C). Careful analysis of the gene products from
this cluster suggests a clear candidate, PA0099, that encodes a
DUF4150-containing protein (aa 18–135) with a C-terminal
putative toxin domain, TOX-GHH2 (aa 226–344), which is a
GHH signature containing HNH/endonuclease VII superfam-
ily nuclease toxin 2with a characteristic S(A/G/P)HH signature
motif (Fig. 8D). To verify this hypothesis, a doublemutant lack-
ing both the vgrG1a and vgrG1c genes (PAKretSvgrG1ac)
and a triple mutant lacking vgrG1ac and PA0099 were con-
structed. In the vgrG1acmutant, vgrG1b is still present, and the
strain is far more toxic to E. coli than the strain lacking all three
vgrG1abc genes (Fig. 8B). However, upon introduction of the
PA0099 deletion in the vgrG1ac mutant, the killing is totally
lost. This observation suggests that theVgrG1b-dependent kill-
ing requires PA0099 and confirms the status of this protein as
an anti-bacterial effector.
Another Rhs Toxin/Immunity Pair Is Encoded on the PA14
Genome—The assortment of variable VgrG-associated toxins
prompted us to investigate other related genomes, including
the P. aeruginosa strain PA14. It has been previously shown
that the P. aeruginosa PA14 strain carries additional genes in
the vicinity of the H2-T6SS cluster that are absent in PAO1.
This set of four genes (Fig. 9A) encodes a Hcp protein (Hcp2), a
VgrG protein (VgrG14), a putative protein of unknown func-
FIGURE 6. Contributionof VgrG1a to the T6SS-mediated killing.Quantification
of bacterial killing by the P.aeruginosa strains PAKretS, PAKretStsei1–
3vgrG1abc, PAKretStsei1–3vgrG1abc::vgrG1a, PAKretStsei1–3vgrG1abc
rhsP1, PAKretStsei1–3vgrG1abcrhsP1::vgrG1c, and PAKretStsei1-
3vgrG1abcrhsP1::vgrG1a against DH5 expressing GFP is shown. The level
of fluorescence indicates survival of E. coli. Bacterial spots (similar to what is
shown in Fig. 2A) were resuspended, and the relative fluorescence, reflecting
E. coli survival, was measured and reported in arbitrary units (A.U.). Comple-
menting the triple vgrG mutant with vgrG1a restores killing (compare the
second and third columns starting from the left). VgrG1a-dependent killing
could be observed in the absence of RhsP1, which is not the case for vgrG1c
complementation (compare the fifth and sixth columns).
FIGURE 7. PA0093 is a H1-T6SS effector protein that requires VgrG1a
for killing. A, genetic organization of the vgrG1a cluster vgrG1a (PA0091)
in red, PA0093 encoding the putative toxin in blue, and genes with no clear
function in black. B, A schematic illustration of the domain organization of
PA0093 is shown. Indicated are the PAAR region, the predicted toxin
domain (Toxin_61), and its associated conserved motif (K/R)STXXPXXD
XX(S/T) (RSTAAPTDDFWS). C, quantification of bacterial killing using
PAKretS, PAKretStsei1–3vgrG1abc, PAKretStsei1–3vgrG1bc, and
PAKretStsei1–3vgrG1bcPA0093 against DH5 expressing GFP. Bac-
terial spots (similar to what is shown in Fig. 2A) were resuspended, and the
relative fluorescence, reflecting E. coli survival, was measured and
reported in arbitrary units (A.U.). The presence of vgrG1a confers the abil-
ity to kill E. coli. The deletion of PA0093 abolishes this killing and high-
lights its role as a toxin dependent on VgrG1a.
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tion (PA14_43090), and a Rhs element (PA14_43100) named
RhsP2 (Fig. 9B) (49) and also carries a C-terminal domain
(RhsP2-CT). The toxic activity observed for RhsP1-CT led us to
further investigate the potential toxicity exerted by RhsP2-CT.
Upon close inspection, a small ORF (435 bp) predicted to
encode an associated putative immunity (RhsI2) was identified
9 bp downstream of the stop codon of rhsP2 (Fig. 9A), which
was not indicated in the original genome annotation. The genes
encoding RhsP2-CT and RhsI2 were cloned separately into
compatible plasmids as described for RhsP1. Overexpression of
RhsP2-CT severely compromised growth of the producing
strain (Fig. 9C), but co-expression of RhsI2 could rescue
growth. This observation thus confirmed the existence of an
additional toxin/immunity pair in selected strains of P.
aeruginosa.
DISCUSSION
The evolved V. choleraeVgrG1, displaying a C-terminal exten-
sion bearing an actin cross-linking domain (ACD), has been con-
sidered for a long time as the archetype substrate injected by the
T6SS into eukaryotic cells (50–53). Since then only a few T6SS
effectors have been shown to target eukaryotic cells (54). In
more recent years the T6SS has been described as a potent
weapon for bacterial warfare (2, 55). The discovery of three
bacterial toxins delivered by the P. aeruginosa H1-T6SS has
sparked this new concept, which is now widespread across
Gram-negative bacterial species (56). Families of T6SS bacterial
toxins have been studied in detail, such as the cell wall-degrad-
ing effectors (25). Twowell characterized representatives, Tse1
and Tse3, are secreted by the H1-T6SS (24). Tse1 targets the
peptide cross-links of the peptidoglycan, whereas Tse3 attacks
the glycan backbone. Tse1 belongs to the family of type VI ami-
dase effector (Tae), whereas Tse3 is a member of the T6SS
glycoside hydrolase (Tge) (57). Other widespread toxins, such
as the Type VI lipase effectors (Tle) have been shown to target
cell membrane. In P. aeruginosa, Tle5 exhibits a phospholipase
activity and has been suggested to be secreted by the H2-T6SS
(58). Few other toxins, such as the bacteriostatic Tse2 toxin
secreted by the H1-T6SS, have yet unknown function but are
likely to exert toxicity within the cytoplasm (23). In all cases,
each toxin is co-produced with an immunity protein, and the
FIGURE 8. PA0099 is an effector protein that requires VgrG1b for kill-
ing. A, bacterial killing assay using the P. aeruginosa strains PAKretS,
PAKretStsei1–3vgrG1abc and PAKretStsei1–3vgrG1abc::vgrG1b
against DH5 expressingGFP. Bacterial spotswere resuspended fromplates
(as shown in Fig. 2A), and the relative fluorescence, reflecting E. coli survival,
was measured and reported in arbitrary units (A.U.). The presence of VgrG1b
contributes to the bacterial killing (third lane). B, quantification of bacterial
killing assay using the P. aeruginosa strains PAKretS, PAKretSvgrG1abc,
PAKretSvgrG1ac, and PAKretSvgrG1acPA0099 against DH5 express-
ingGFP. Quantificationwas performed as in panel A. Deletion of PA0099 (fifth
lane) abrogates VgrG1b-dependent killing (fourth lane). C, genetic organiza-
tion of the vgrG1b cluster highlighting vgrG1b (PA0095) in red, PA0099, the
putative toxin, in blue, and genes with no clear function are colored black. D,
schematic representation of PA0099 displaying the DUF4150 domain, the
Tox-GHH2 domain, and the characteristic S(A/G/P)HH motif located within
this domain.
FIGURE 9. RhsP2 and RhsI2 form a toxin/immunity pair. A, genetic orga-
nization of the vgrG14 cluster showing hcp2 (PA14_43070), vgrG14
(PA14_43080), a gene encoding aprotein of unknown functionPA14_43090,
rhsP2 (PA14_43100), and a small non-annotated ORF rhsI2 encoding for a
putative immunity protein. B, schematic representation of RhsP2 displaying
the N-terminal region, RVXXXXXXXXG motif, conserved Rhs core domain,
PXXXXDPXGL motif, and the C-terminal domain (RhsP2-CT). C, monitoring
growth (A600) in LB medium of E. coli Top10 cells harboring pRhsP2-CT and
pRhsI2. Cultures were induced at the time indicated (see the arrow) with
either 1 mM isopropyl 1-thio--D-galactopyranoside (expression of the
RhsP2-CT toxin) or 0.02% arabinose (expression of the RhsI2 immunity).
Expression of RhsP2 compromisedgrowth (red curve), whereas co-expression
of RhsI2 rescues growth (orange curve).
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localization of the immunity matches the site of action of the
toxin, i.e. cytoplasmic, periplasmic, or membranes. It is quite
reasonable to propose that many more toxins could be iden-
tified and random approaches involving Tn-seq methodolo-
gies have uncovered yet unidentified T6SS immunity genes
and subsequently pointed toward their cognate T6SS toxins
(33).
In contrast to evolved VgrGs, the mechanism of T6SS-de-
pendent transport of genuine bacterial T6SS toxins is open for
discussion. A recent report proposed that Hcp acts as a chap-
erone for Tse2 (31). This observation suggests a delivery of this
toxin to the target cell through the tubular structure of theT6SS
(59–61). However, the V. cholerae VgrG3 is an evolved VgrG
unrelated to Tae or Tge but is involved in the degradation of
peptidoglycan in prey cells (32, 33). In this case, it could be
proposed that theVgrG3 effector localizes at the tip of theT6SS
tubular structure allowing it to reach the surface but would not
travel within it. These various transport models have been dis-
cussed further in light of the characterization of PAAR compo-
nents, which could be used as a linker between a non-evolved
VgrG and a genuine T6SS toxin (6).
Here we characterized the contribution of three VgrG pro-
teins, VgrG1abc (22), to the bacterial killing associated with the
H1-T6SS of P. aeruginosa (34). The deletion of the three vgrG
genes co-regulated with the H1-T6SS fully abrogated toxicity.
Investigating the genetic environment of each one of the three
vgrG genes revealed putative toxin-encoding genes. The gene
located downstream of vgrG1c encodes RhsP1, and its C termi-
nus, RhsP1-CT, contributes to bacterial killing. The toxin is
neutralized by a putative immunity coded by a downstream
gene, which was not annotated on the P. aeruginosa genome
(62). This putative immunity protein has two predicted trans-
membrane domains and is located in the cytoplasmic mem-
brane, suggesting that the target of RhsP1-CT is membrane-
associated. The introduction of VgrG1c in a strain lacking the
RhsP1-encoding gene does not restore killing, whereas intro-
duction of VgrG1a in the same background results in bacterial
killing. This suggests that in contrast to the Tse1–3-dependent
killing, RhsP1 toxicity is specific to VgrG1c, which cannot be
substituted with another similar protein. In fact, VgrG1a-de-
pendent killing involves another toxin coded by the PA0093
gene located downstream of the vgrG1a gene. The C terminus
of PA0093 is predicted (Pfam) to carry a putative toxin domain
of unknown function (Toxin_61). Finally, VgrG1b indepen-
dently contributes to the killing of E. coli. This is particularly
interesting as VgrG1b secretion has been demonstrated to be
H1-T6SS-independent (22). Bioinformatic analysis of the
vgrG1b gene cluster (PA0096-PA0101) predicted PA0099 as a
two-domain protein, with a C terminus belonging to the puta-
tive superfamily of nuclease toxins. Two Rhs proteins in
D. dadantii, RhsA and RhsB, have been reported to carry a C
terminus with a DNase activity (47). It was proposed that these
proteins are involved in bacterial competition and requires
adjacent vgrG genes to fulfill their function, although T6SS-de-
pendent delivery involving other core T6SS components was
not demonstrated.
Collectively, our data suggest that VgrG proteins could be
considered as specific carriers for the delivery of cognate
toxins. We identified three specific VgrG/toxin couples,
namely VgrG1a/PA0093, VgrG1b/PA0099, and VgrG1c/
RhsP1. It is likely that these combinations are not inter-
changeable, which is in marked contrast to what was
observed for the Tse1–3 effectors. We can then speculate
that each individual VgrG recognizes a cognate toxin and
allow its delivery to a bacterial target. This mechanism could
be related to the one exemplified by VgrG3 of V. cholerae,
although in this case VgrG and the bacterial toxin are cova-
lently linked (32, 33). In the case of VgrG1abc, the recogni-
tion is most likely indirect and may involve adaptor proteins
such as PAAR proteins (6). Yet the putative PA0093 toxin
associated with VgrG1a displays a PAAR domain at its N
terminus, which may interact with VgrG1a. This configura-
tion offers a combination in which the VgrG adaptor is not
independent but connected to the toxin. The organization at
the tip of the T6SS can thus be relatively diverse and would
provide a modular platform for the positioning of a broad
range of T6SS effectors. Nevertheless, VgrG proteins might
still recognize more than one T6SS effector. For example, in
V. cholerae, VgrG3 presents a built-in toxin at its C terminus
but was shown to interact with another T6SS toxin, TseL,
which displays a lipase activity.
The strict connection between VgrG and effectors could be a
more general feature, and the delivery of these effectors can in
some cases be independent of other core T6SS components.
The role of VgrG1b in bacterial toxicity, although it has been
shown previously to be H1-T6SS independent, supports this
idea. The observation that RhsA and RhsB in D. dadantii are
VgrG-dependent but have not been shown to be T6SS-depen-
dent is also supportive of such amodel. Finally, the existence of
a large number of vgrG islands, which are not necessarily con-
nected to T6SS core genes, also lends support to an original
VgrG-dependent transport. For example, several additional
vgrG gene clusters found in the P. aeruginosa genome present
recognizable toxin-encoding genes. In the P. aeruginosa PA14
genome, PA14_69550 encodes VgrG5. A downstream gene,
PA14_69520, encodes a protein of which the C terminus has a
high similarity with the E. coli colicin 1a (63), as predicted using
the Phyre software (43). The next gene, PA14_69510, encodes a
proteinwith three predicted transmembrane domains, which is
an ideal candidate to protect from the activity of this pore-
forming protein. Another example is the vgrG cluster adjacent
to the H2-T6SS cluster in PA14 and is lacking in PAO1 (49, 64,
65). In this case the vgrG14 gene is clustered with a gene encod-
ing RhsP2, whose C terminus displays a proven bacterial toxin
activity.
A VgrG-dependent concept is an interesting development
in T6SS research and could lead to distinguish an interme-
diate secretion strategy, more straightforward and relying
exclusively on VgrG. This could be used for large-sized pro-
teins and be similar to the CDI system that has been
described in many instances and in which a combination of
only two partners is involved (66). CdiA is a very large pro-
tein with a C terminus carrying the toxin activity and could
thus be very comparable to the Rhs proteins. CdiA is trans-
ported by a single transporter of the TpsB/Omp85 family,
CdiB. It is tempting to suggest that in some cases VgrG could
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act as a CdiB transporter and be the main facilitator in the
secretion process, independently of T6SS core components.
This remains an attractive hypothesis, but if true, it shall
involve a different mechanism, which may explain many of
the poorly understood aspects of the T6SS.
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